BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6206798)

  • 1. [The evaluation of the treatment for esophageal cancer with tubed solidified bleomycin (TS-BLM)].
    Watanabe H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1563-8. PubMed ID: 6206798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant chemotherapy and surgery of esophageal cancer--results of application of a slow-releasing solid bleomycin tube for the enhancement of the effect of radical surgery].
    Watanabe H
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2067-76. PubMed ID: 6191692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of bleomycin adsorbed on to activated carbon particles by regional lymph nodes of the esophagus in dogs.
    Shimada M; Aikou T; Natsugoe S; Shimazu H; Nakamura K
    Anticancer Drug Des; 1993 Aug; 8(4):249-55. PubMed ID: 7694587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Submucosal injection of lipiodol-bleomycin in esophageal cancer].
    Yamashita Y; Hirai T; Mukaida H; Kawano K; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2075-9. PubMed ID: 2471463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An attempt to treat esophageal cancer by intraoperative local administration of oil bleomycin].
    Nomi A; Watanabe Y; Tamura J; Suzuki M; Tsumura H; Sakakibara N
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):649-54. PubMed ID: 1690968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loco-regional treatment for esophageal cancer with bleomycin adsorbed to activated carbon particles.
    Natsugoe S; Aikou T; Shimada M; Kumanohoso T; Shimazu H; Nakamura K
    Anticancer Res; 1993; 13(5C):1785-7. PubMed ID: 7505542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
    Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multidisciplinary treatment of esophageal cancer].
    Kuwano H; Sadanaga N; Watanabe M; Ikebe M; Mori M; Sugimachi K
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1167-72. PubMed ID: 7687421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transnodal cancer chemotherapy for metastatic lymph nodes in rats.
    Matsuzaki K; Natsuda Y; Kai H; Sugimachi K
    Cancer Treat Rep; 1987 Mar; 71(3):235-9. PubMed ID: 2434225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity of esophageal cancer to anticancer agents and supplementary chemotherapy combined with surgical treatment].
    Masaki Y; Ishigami K; Oka M; Matsumoto N; Honma K; Uchiyama T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1163-8. PubMed ID: 2425741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of bleomycin adsorbed on silica particles against lymph node metastasis in patients with esophageal cancer: a pilot study.
    Natsugoe S; Shimada M; Kumanohoso T; Tokuda K; Baba M; Yoshinaka H; Fukumoto T; Nakamura K; Yamada K; Nakashima T
    Surgery; 1995 Jun; 117(6):636-41. PubMed ID: 7539941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrence of esophageal cancer treated by combination TS-1/CDDP therapy].
    Hiraki M; Yunotani S; Noguchi R; Shinozaki Y; Tani H; Sakai M; Ishimitsu T; Tabuchi M
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):219-21. PubMed ID: 15751636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between dissection of lymph nodes adjacent to mesenteric artery pedicle and prognosis in colorectal cancer patients].
    Zong XY; Shi YQ
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):32-5. PubMed ID: 16737617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
    Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
    Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multidisciplinary therapy for esophageal carcinoma. Cooperative Study Group for Esophageal Carcinoma].
    Gan No Rinsho; 1984 May; 30(5):449-54. PubMed ID: 6202898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endoscopic mucosal resection for esophageal cancer].
    Momma K; Yoshida M
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):914-9. PubMed ID: 12894703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer.
    Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Komatsu S; Yamagishi H
    Oncol Rep; 2006 Nov; 16(5):1061-6. PubMed ID: 17016593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.